A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).

ABSTRACT:

SUBMITTER: Bellone S 

PROVIDER: S-EPMC9465821 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature